Taxol, ifosfamide, and cisplatin (TIP) followed by high-dose chemotherapy with carboplatin, etoposide and thiotepa (HD-CET) in germ-cell cancer

被引：0
|
作者：
Rick, O
Beyer, J
Bokemeyer, C
Metzner, B
Casper, J
Wandt, H
Hartmann, F
Schmoll, HJ
Kanz, L
Huhn, D
Siegert, W
机构：
[1] Free Univ Berlin, Klinikum Rudolf Virchow, D-1000 Berlin, Germany
[2] Univ Tubingen, Tubingen, Germany
来源：
BONE MARROW TRANSPLANTATION | 1999年 / 23卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
639
引用
收藏
页码：S192 / S192
页数：1
相关论文
共 50 条
  • [1] HIGH-DOSE CARBOPLATIN AND ETOPOSIDE FOR SALVAGE CHEMOTHERAPY OF GERM-CELL TUMORS
    LAMPE, H
    DEARNALEY, DP
    PRICE, A
    MEHTA, J
    POWLES, R
    NICHOLLS, J
    HORWICH, A
    EUROPEAN JOURNAL OF CANCER, 1995, 31A (05) : 717 - 723
  • [2] Thrombocytopenia following high-dose chemotherapy with carboplatin, etoposide and thiotepa in patients with testicular germ cell cancer
    Minichmayr, Iris
    Nock, Valerie
    Jaehde, Ulrich
    Kloft, Charlotte
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2013, 51 (01) : 74 - 76
  • [3] HIGH-DOSE CARBOPLATIN, ETOPOSIDE AND IFOSFAMIDE FOLLOWED BY AUTOLOGOUS STEM-CELL TRANSPLANTATION IN POOR RISK GERM-CELL TUMORS
    SIEGERT, W
    BEYER, J
    STROHSCHEER, I
    WEISBACH, V
    HEUFT, HG
    OETTLE, H
    ZINGSEM, J
    ECKSTEIN, R
    SCHMOLL, HJ
    HUHN, D
    BONE MARROW TRANSPLANTATION, 1992, 10 : 26 - 26
  • [4] Salvage treatment with paclitaxel, ifosfamide, and cisplatin plus high-dose carboplatin, etoposide, and thiotepa followed by autologous stem-cell rescue in patients with relapsed or refractory germ cell cancer
    Rick, O
    Bokemeyer, C
    Beyer, J
    Hartmann, JT
    Schwella, N
    Kingreen, D
    Neureither, S
    Metzner, B
    Casper, J
    Wandt, H
    Hartmann, F
    Schmoll, HJ
    Derigs, G
    Gerl, A
    Berdel, WE
    Kanz, L
    Siegert, W
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (01) : 81 - 88
  • [5] Paclitaxel plus ifosfamide followed by high-dose carboplatin plus etoposide in previously treated germ cell tumors
    Kondagunta, G. Varuni
    Bacik, Jennifer
    Sheinfeld, Joel
    Bajorin, Dean
    Bains, Manjit
    Reich, Lillian
    Deluca, John
    Budnick, Amy
    Ishill, Nicole
    Mazumdar, Madhu
    Bosl, George J.
    Motzer, Robert J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (01) : 85 - 90
  • [6] HIGH-DOSE TREATMENT WITH CARBOPLATIN, ETOPOSIDE, AND IFOSFAMIDE FOLLOWED BY AUTOLOGOUS STEM-CELL TRANSPLANTATION IN RELAPSED OR REFRACTORY GERM-CELL CANCER - A PHASE I/II STUDY
    SIEGERT, W
    BEYER, J
    STROHSCHEER, I
    BAURMANN, H
    OETTLE, H
    ZINGSEM, J
    ZIMMERMANN, R
    BOKEMEYER, C
    SCHMOLL, HJ
    HUHN, D
    JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (06) : 1223 - 1231
  • [7] SALVAGE CHEMOTHERAPY OF NONSEMINOMATOUS GERM-CELL TUMORS - PHASE-II TRIAL OF AN ETOPOSIDE, IFOSFAMIDE AND HIGH-DOSE CISPLATIN (VLHP) COMBINATION
    RIBRAG, V
    DROZ, JP
    BOULEUC, C
    THEODORE, C
    GHOSN, M
    PICO, JL
    AZAB, M
    OSTRONOFF, M
    HAYAT, M
    PRESSE MEDICALE, 1990, 19 (27): : 1263 - 1266
  • [8] SALVAGE CHEMOTHERAPY IN REFRACTORY GERM-CELL TUMORS WITH ETOPOSIDE (VP-16) PLUS IFOSFAMIDE PLUS HIGH-DOSE CISPLATIN - A VIHP REGIMEN
    GHOSN, M
    DROZ, JP
    THEODORE, C
    PICO, JL
    BAUME, D
    SPIELMANN, M
    OSTRONOFF, M
    MORAN, A
    SALLOUM, E
    KRAMAR, A
    HAYAT, M
    CANCER, 1988, 62 (01) : 24 - 27
  • [9] Bevacizumab plus high-dose ifosfamide, etoposide and carboplatin (HD-ICE) as third-line salvage chemotherapy induced an unexpected dramatic response in highly platinum refractory germ-cell cancer
    Voigt, W
    Kegel, T
    Maher, G
    Jordan, K
    Müller, L
    Schmoll, HJ
    ANNALS OF ONCOLOGY, 2006, 17 (03) : 531 - U6
  • [10] Nephrotoxicity after high-dose carboplatin, etoposide and ifosfamide in germ-cell tumors: incidence and implications for hematologic recovery and clinical outcome
    J Beyer
    O Rick
    S Weinknecht
    D Kingreen
    K Lenz
    W Siegert
    Bone Marrow Transplantation, 1997, 20 : 813 - 819
12345